R Honeywell Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

1/2014

Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Honeywell Research Topics

Disease

2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2013 - 03/2012
2	Malaria 05/2000 - 05/2000
2	Acquired Immunodeficiency Syndrome (AIDS) 05/2000 - 05/2000
1	Hypoxia (Hypoxemia) 01/2014
1	Neoplasms (Cancer) 01/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2014
1	Kwashiorkor 05/2000
1	Infections 05/2000
1	Falciparum Malaria (Plasmodium falciparum Malaria) 05/2000

Drug/Important Bio-Agent (IBA)

2	Gemcitabine FDA Link 01/2014 - 03/2012
2	Caffeine (No Doz)FDA LinkGeneric 05/2000 - 05/2000
2	1,7-dimethylxanthine (paraxanthine)IBA 05/2000 - 05/2000
1	Metalloproteases (Metalloproteinases)IBA 01/2014
1	Lactate Dehydrogenase 5IBA 01/2014
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2013
1	Sorafenib (BAY 43-9006)FDA Link 01/2013
1	Cytidine DeaminaseIBA 03/2012
1	PlatinumIBA 03/2012
1	Theophylline (Theon)FDA LinkGeneric 05/2000
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2000
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 05/2000
1	TheobromineIBA 05/2000